Skip to content
10-K

Annual Report

Lipocine Inc. LPCN

0001493152-26-009411

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 9, 2026 7.3M sh
Shares Diluted FY 2025 · Dec 31, 2025 5.71M sh
Shares Diluted FY 2025 · Dec 31, 2024 5.42M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.76M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.22M
Cash And Equivalents FY 2025 · Dec 31, 2025 $5.21M
Cash And Equivalents FY 2025 · Dec 31, 2024 $6.21M
Stockholders Equity FY 2025 · Dec 31, 2025 $14.48M
Stockholders Equity FY 2025 · Dec 31, 2024 $21M
Stockholders Equity FY 2025 · Dec 31, 2023 $20.37M
Current Liabilities FY 2025 · Dec 31, 2025 $2.53M
Current Liabilities FY 2025 · Dec 31, 2024 $1.51M
Total Liabilities FY 2025 · Dec 31, 2025 $2.53M
Total Liabilities FY 2025 · Dec 31, 2024 $1.51M
Current Assets FY 2025 · Dec 31, 2025 $16.88M
Current Assets FY 2025 · Dec 31, 2024 $22.32M
Total Assets FY 2025 · Dec 31, 2025 $17.01M
Total Assets FY 2025 · Dec 31, 2024 $22.51M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.69
Eps Basic FY 2025 · Dec 31, 2025 −$1.77
Sga Expense FY 2025 · Dec 31, 2025 $3.76M
Sga Expense FY 2025 · Dec 31, 2024 $5M
Rd Expense FY 2025 · Dec 31, 2025 $8.58M
Rd Expense FY 2025 · Dec 31, 2024 $7.35M
Net Income FY 2025 · Dec 31, 2025 −$9.63M
Net Income FY 2025 · Dec 31, 2024 $8.35K
Operating Income FY 2025 · Dec 31, 2025 −$10.37M
Operating Income FY 2025 · Dec 31, 2024 −$1.16M
Capex FY 2025 · Dec 31, 2024 $90.09K